Phase 2 Study of the Anti-Angiogenesis Agent AG-013736 in Patients with Poor Prognosis Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS).

Autor: Giles, Francis J., Steinfeldt, Heidi *, Bellamy, William T. *, Bycott, Paul *, Pithavala, Yazdi *, Reich, Steven D. *, List, Alan F.
Zdroj: In Blood 16 November 2004 104(11):1813-1813
Databáze: ScienceDirect